Filing Details

Accession Number:
0001209191-13-020013
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-03 12:53:04
Reporting Period:
2013-04-01
Filing Date:
2013-04-03
Accepted Time:
2013-04-03 12:53:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283535 Gary Patou C/O Mpm Asset Management
601 Gateway Blvd., Suite 350
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-01 30,000 $1.61 30,000 No 4 M Direct
Common Stock Disposition 2013-04-01 18,700 $27.75 11,300 No 4 S Direct
Common Stock Disposition 2013-04-01 11,300 $28.82 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2013-04-01 30,000 $0.00 30,000 $1.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,042 2020-09-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 115 Indirect See Footnote
Footnotes
  1. This transaction was pursuant to a 10b5-1 Plan.
  2. Represents weighted average sales price. The shares were sold at prices ranging from $27.23 to $28.20. The Reporting Person will provide upon request, to the SEC, the Issuer or securityholder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Represents weighted average sales price. The shares were sold at prices ranging from $28.27 to $28.93. The Reporting Person will provide upon request, to the SEC, the Issuer or securityholder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. Shares held by Patou Family Trust, of which the reporting person is trustee.
  5. The option vests as to 50% of the option shares on September 2, 2010 and the remaining 50% of the option shares vests equally monthly over the next 24 months.